Microarray analysis of bone marrow-derived macrophage cells treated with Kdo2-lipid A (KLA) and ATP

Search by fold change ratio | Search by KEGG pathway | Search by LIPID MAPS lipid pathway

Kdo2-Lipid A / ATP gene array data - treatment:control ratios

KEGG pathway: Pertussis (mmu05133)

Legend:graph_icon: View data/graphs for replicates
Gene symbol    Time course plot Accession Description Treatment 15min 30min 1hr 2hr 4hr 8hr 20hr
C1qa
KLA  ATP  ATP+KLA
 NM_007572 complement component 1, q subcomponent, alpha polypeptide (C1qa), mRNA [NM_007572] KLA 1.12 1.11 1.09 .94 1.11 1.12 1.31
ATP 1.14 1.21 .88 1.16 .90 .67 .95
KLA/ATP 1.12 1.23 .93 1.27 .86 .81 .91
C1qb
KLA  ATP  ATP+KLA
 NM_009777 complement component 1, q subcomponent, beta polypeptide (C1qb), mRNA [NM_009777] KLA 1.01 1.14 1.20 1.15 1.31 1.15 1.06
ATP 1.16 1.20 .84 1.27 1.02 .70 .76
KLA/ATP 1.29 1.36 .95 1.28 1.00 .97 .85
C1qc
KLA  ATP  ATP+KLA
 NM_007574 complement component 1, q subcomponent, C chain (C1qc), mRNA [NM_007574] KLA 1.03 .97 1.01 1.04 1.07 1.13 1.15
ATP 1.07 1.06 .91 .94 .77 .62 .82
KLA/ATP 1.08 1.02 .95 1.04 .76 .73 .66
C1r
KLA  ATP  ATP+KLA
 NM_023143 complement component 1, r subcomponent (C1r), mRNA [NM_023143] KLA 8.09 7.91 7.94 8.52 7.04 6.64 3.85
ATP .96 .88 1.02 .92 .86 1.28 1.82
KLA/ATP 7.33 7.67 7.74 6.90 4.82 3.90 3.88
C1s
KLA  ATP  ATP+KLA
 NM_144938 complement component 1, s subcomponent (C1s), transcript variant 1, mRNA [NM_144938] KLA 1.32 1.25 1.42 1.28 1.26 1.18 1.22
ATP 1.00 1.04 1.04 1.06 1.02 1.12 1.21
KLA/ATP 1.34 1.30 1.19 1.19 1.15 1.18 1.21
C2
KLA  ATP  ATP+KLA
 NM_013484 complement component 2 (within H-2S) (C2), mRNA [NM_013484] KLA 1.84 2.05 2.15 2.41 2.47 2.93 3.16
ATP .96 .96 1.22 1.18 1.15 1.16 1.42
KLA/ATP 1.81 2.00 2.25 1.92 1.84 2.10 2.96
C3
KLA  ATP  ATP+KLA
 NM_009778 complement component 3 (C3), mRNA [NM_009778] KLA 28.58 25.57 24.39 27.34 23.38 23.21 18.10
ATP 1.04 .93 1.21 1.90 2.80 5.74 12.19
KLA/ATP 27.04 26.10 33.29 23.09 25.65 23.77 40.22
C4b
KLA  ATP  ATP+KLA
 NM_009780 complement component 4B (Childo blood group) (C4b), mRNA [NM_009780] KLA 1.46 1.50 1.67 1.58 1.87 1.68 1.33
ATP 1.05 .99 .95 .87 .88 .79 .66
KLA/ATP 1.39 1.62 1.52 1.32 1.36 1.03 .73
C4bp
KLA  ATP  ATP+KLA
 AK050344 adult male liver tumor cDNA, RIKEN full-length enriched library, clone:C730039N23 product:hypothetical protein, full insert sequence. [AK050344] KLA .92 .99 .98 1.00 1.02 .97 .98
ATP 1.02 1.03 .96 .99 1.02 .96 .97
KLA/ATP .99 1.03 1.04 .95 .92 .93 .96
C4bp
KLA  ATP  ATP+KLA
 NM_007576 complement component 4 binding protein (C4bp), mRNA [NM_007576] KLA 1.10 1.00 .94 .98 1.02 .97 .99
ATP .94 .98 1.05 .99 .96 .98 .99
KLA/ATP .95 .93 1.06 1.02 1.09 1.05 .96
Calm1
KLA  ATP  ATP+KLA
 NM_009790 calmodulin 1 (Calm1), mRNA [NM_009790] KLA 1.20 1.26 1.30 1.06 1.16 1.09 1.18
ATP 1.07 1.20 1.00 1.29 .99 .64 .58
KLA/ATP 1.31 1.31 .93 1.31 .97 .83 .59
Calm2
KLA  ATP  ATP+KLA
 NM_007589 calmodulin 2 (Calm2), mRNA [NM_007589] KLA .79 .81 .71 .67 .54 .45 .64
ATP .99 1.03 1.04 .93 .82 .52 .76
KLA/ATP .76 .78 .76 .77 .73 .47 .42
Calm3
KLA  ATP  ATP+KLA
 NM_007590 calmodulin 3 (Calm3), mRNA [NM_007590] KLA .95 .96 .93 1.03 1.05 1.08 1.00
ATP .93 .96 .99 .97 .93 .84 .72
KLA/ATP .89 .93 .90 .91 1.02 .98 .70
Calm4
KLA  ATP  ATP+KLA
 NM_020036 calmodulin 4 (Calm4), mRNA [NM_020036] KLA 1.02 .96 1.05 1.00 .99 1.00 1.01
ATP 1.10 1.05 1.03 1.01 .94 .98 .98
KLA/ATP .99 1.12 1.01 1.03 .98 1.07 1.02
Calm5
KLA  ATP  ATP+KLA
 NM_001008706 calmodulin 5 (Calm5), mRNA [NM_001008706] KLA 1.02 1.11 .99 .98 1.07 1.01 1.09
ATP 1.07 1.05 1.04 1.04 1.01 1.04 .99
KLA/ATP 1.00 1.00 .97 1.07 1.00 1.07 .98
Calml3
KLA  ATP  ATP+KLA
 NM_027416 calmodulin-like 3 (Calml3), mRNA [NM_027416] KLA 1.01 .95 1.05 .91 1.01 .98 .89
ATP .91 1.05 1.04 1.01 .93 1.07 .99
KLA/ATP 1.01 .96 .97 .96 .97 .92 .99
Casp1
KLA  ATP  ATP+KLA
 NM_009807 caspase 1 (Casp1), mRNA [NM_009807] KLA 4.27 4.63 5.39 6.07 5.87 5.49 2.96
ATP .93 .87 1.01 .80 1.05 3.11 2.77
KLA/ATP 4.31 4.18 5.40 4.00 4.66 4.90 7.20
Casp3
KLA  ATP  ATP+KLA
 NM_009810 caspase 3 (Casp3), mRNA [NM_009810] KLA 1.66 1.94 2.47 2.61 3.01 2.96 1.44
ATP .90 .99 1.17 1.30 1.01 1.17 .86
KLA/ATP 1.55 1.87 2.40 2.35 2.27 2.84 2.52
Casp3
KLA  ATP  ATP+KLA
 U49929 ICE-like cysteine protease (Lice) mRNA, complete cds. [U49929] KLA 1.71 1.87 2.69 3.11 3.64 3.42 1.52
ATP 1.04 1.07 1.16 1.34 .98 1.27 .86
KLA/ATP 1.80 1.96 2.46 2.91 2.50 3.24 3.10
Casp7
KLA  ATP  ATP+KLA
 NM_007611 caspase 7 (Casp7), mRNA [NM_007611] KLA 3.50 3.60 4.52 5.05 5.20 2.96 1.27
ATP 1.03 1.14 1.20 1.27 .82 .77 .84
KLA/ATP 3.32 3.86 3.98 5.27 3.49 2.55 2.30
Cd14
KLA  ATP  ATP+KLA
 NM_009841 CD14 antigen (Cd14), mRNA [NM_009841] KLA 2.35 2.68 2.54 2.21 2.39 1.52 1.57
ATP 1.44 2.28 2.82 3.98 6.68 16.14 6.92
KLA/ATP 2.92 3.79 3.96 5.12 5.29 10.42 11.50
Cfl1
KLA  ATP  ATP+KLA
 NM_007687 cofilin 1, non-muscle (Cfl1), mRNA [NM_007687] KLA .90 1.01 1.14 .87 1.17 1.17 1.48
ATP 1.24 1.60 .81 1.77 1.07 .88 1.27
KLA/ATP 1.33 1.48 .50 1.58 .71 .93 1.31
Cfl2
KLA  ATP  ATP+KLA
 NM_007688 cofilin 2, muscle (Cfl2), mRNA [NM_007688] KLA .62 .65 .74 .97 .99 .97 1.03
ATP .57 .49 .50 .49 .94 .97 .76
KLA/ATP .47 .41 .44 .58 1.02 1.05 .93
Cxcl5
KLA  ATP  ATP+KLA
 NM_009141 chemokine (C-X-C motif) ligand 5 (Cxcl5), mRNA [NM_009141] KLA 1.27 1.29 1.18 1.21 1.14 1.07 1.08
ATP 1.02 .99 1.08 1.10 1.92 18.34 20.38
KLA/ATP 1.27 1.26 1.26 1.24 1.23 4.06 29.52
EG317677
KLA  ATP  ATP+KLA
 NM_173864 predicted gene, EG317677 (EG317677), mRNA [NM_173864] KLA .99 .99 1.01 1.01 .97 .98 1.06
ATP 1.00 1.01 1.05 1.05 .98 .99 1.01
KLA/ATP 1.00 1.00 .99 1.02 1.01 1.01 1.02
Fos
KLA  ATP  ATP+KLA
 NM_010234 FBJ osteosarcoma oncogene (Fos), mRNA [NM_010234] KLA .42 .33 .64 .61 .71 .85 .71
ATP 3.48 5.46 23.78 25.22 1.71 2.36 1.50
KLA/ATP .90 1.74 5.97 8.62 1.28 2.42 4.52
Gnai1
KLA  ATP  ATP+KLA
 NM_010305 guanine nucleotide binding protein (G protein), alpha inhibiting 1 (Gnai1), mRNA [NM_010305] KLA .95 1.01 1.01 1.00 1.09 1.10 1.08
ATP 1.06 1.06 .99 1.15 1.02 .94 .99
KLA/ATP 1.02 1.04 .99 1.16 1.01 1.02 1.13
Gnai2
KLA  ATP  ATP+KLA
 NM_008138 guanine nucleotide binding protein (G protein), alpha inhibiting 2 (Gnai2), mRNA [NM_008138] KLA .74 .79 .82 .74 .91 .97 1.10
ATP 1.07 1.16 .78 1.12 .78 .48 .82
KLA/ATP .91 .81 .53 .80 .60 .68 .87
Gnai3
KLA  ATP  ATP+KLA
 NM_010306 guanine nucleotide binding protein (G protein), alpha inhibiting 3 (Gnai3), mRNA [NM_010306] KLA 1.23 1.24 1.14 1.06 .99 1.15 1.09
ATP .96 .93 .86 .64 1.34 2.02 1.35
KLA/ATP 1.20 1.24 .97 .76 1.21 1.62 1.17
Hc
KLA  ATP  ATP+KLA
 NM_010406 hemolytic complement (Hc), mRNA [NM_010406] KLA 1.07 1.12 1.05 .98 1.12 1.12 1.08
ATP .96 .93 1.12 1.07 1.34 5.60 1.48
KLA/ATP 1.05 1.18 1.12 1.05 1.13 3.40 4.37
Il10
KLA  ATP  ATP+KLA
 NM_010548 interleukin 10 (Il10), mRNA [NM_010548] KLA 17.59 18.64 22.22 23.06 11.83 8.27 2.07
ATP 1.86 3.22 7.72 20.51 25.86 8.38 1.01
KLA/ATP 17.91 23.49 34.53 34.48 20.98 12.03 8.17
Il12a
KLA  ATP  ATP+KLA
 NM_008351 interleukin 12a (Il12a), mRNA [NM_008351] KLA 2.37 2.47 2.17 1.49 1.46 1.12 1.20
ATP 1.01 .97 1.12 1.07 1.02 1.07 1.06
KLA/ATP 2.01 2.76 2.54 1.70 1.08 1.10 1.27
Il12b
KLA  ATP  ATP+KLA
 NM_008352 interleukin 12b (Il12b), mRNA [NM_008352] KLA 194.79 211.32 198.97 173.01 142.24 40.28 3.10
ATP 1.05 1.10 1.59 1.99 2.71 2.72 1.52
KLA/ATP 191.27 223.23 280.10 224.29 183.03 68.43 10.69
Il1a
KLA  ATP  ATP+KLA
 NM_010554 interleukin 1 alpha (Il1a), mRNA [NM_010554] KLA 32.45 35.22 31.30 20.95 28.57 18.36 19.02
ATP 1.04 1.02 2.21 5.46 11.06 32.07 3.40
KLA/ATP 32.02 41.20 35.12 46.91 28.76 42.72 57.80
Il1b
KLA  ATP  ATP+KLA
 NM_008361 interleukin 1 beta (Il1b), mRNA [NM_008361] KLA 149.78 133.59 100.91 116.58 86.48 89.37 64.72
ATP 3.49 13.96 61.44 70.91 82.12 162.79 28.18
KLA/ATP 130.32 139.00 219.12 148.17 165.44 172.57 146.98
Il23a
KLA  ATP  ATP+KLA
 NM_031252 interleukin 23, alpha subunit p19 (Il23a), mRNA [NM_031252] KLA 1.36 1.46 1.33 1.20 1.05 1.04 1.02
ATP .99 1.01 1.06 1.36 1.25 1.07 1.02
KLA/ATP 1.52 1.62 1.48 1.60 1.23 1.12 1.07
Il6
KLA  ATP  ATP+KLA
 NM_031168 interleukin 6 (Il6), mRNA [NM_031168] KLA 352.99 378.70 276.81 168.47 59.99 18.66 8.27
ATP 1.04 1.08 2.28 3.69 30.40 161.93 2.11
KLA/ATP 334.28 528.66 ###.## 935.86 302.45 355.36 99.65
Irak1
KLA  ATP  ATP+KLA
 NM_008363 interleukin-1 receptor-associated kinase 1 (Irak1), mRNA [NM_008363] KLA .67 .67 .64 .56 .58 .58 .84
ATP 1.02 1.10 .94 1.14 .81 .54 .87
KLA/ATP .72 .72 .57 .67 .51 .43 .62
Irak4
KLA  ATP  ATP+KLA
 NM_029926 interleukin-1 receptor-associated kinase 4 (Irak4), mRNA [NM_029926] KLA .82 .86 .78 .82 .95 1.21 1.22
ATP 1.02 1.18 .95 1.10 .79 .85 .82
KLA/ATP .86 .89 .77 .90 .78 .96 .88
Irf1
KLA  ATP  ATP+KLA
 NM_008390 interferon regulatory factor 1 (Irf1), mRNA [NM_008390] KLA 10.08 9.47 8.27 7.31 6.74 6.39 3.17
ATP .95 .81 .80 3.61 2.99 4.15 1.77
KLA/ATP 10.40 10.08 6.59 8.23 12.18 7.53 7.82
Irf3
KLA  ATP  ATP+KLA
 ENSMUST00000107835 ens|Interferon regulatory factor 3 (IRF-3). [Source:Uniprot/SWISSPROT;Acc:P70671] [ENSMUST00000107835] KLA .55 .56 .60 .72 .88 .88 .98
ATP .77 .58 .50 .46 .80 .97 1.03
KLA/ATP .51 .46 .49 .53 .92 .85 .79
Irf3
KLA  ATP  ATP+KLA
 NM_016849 interferon regulatory factor 3 (Irf3), mRNA [NM_016849] KLA .79 .75 .71 .83 .88 1.07 .99
ATP .92 .84 .88 .61 .54 1.27 1.22
KLA/ATP .78 .78 .75 .58 .70 1.13 1.38
Irf8
KLA  ATP  ATP+KLA
 NM_008320 interferon regulatory factor 8 (Irf8), mRNA [NM_008320] KLA 4.10 3.85 4.58 3.17 1.81 1.07 1.08
ATP 1.17 1.08 .79 .77 .66 .65 1.31
KLA/ATP 4.52 4.40 3.86 3.83 2.66 1.16 .85
Itga5
KLA  ATP  ATP+KLA
 NM_010577 integrin alpha 5 (fibronectin receptor alpha) (Itga5), mRNA [NM_010577] KLA 2.63 3.04 2.81 2.47 4.61 5.45 4.90
ATP 1.13 1.62 .74 2.21 1.31 1.93 2.84
KLA/ATP 3.55 3.84 1.15 3.03 1.11 2.81 10.42
Itgam
KLA  ATP  ATP+KLA
 NM_001082960 integrin alpha M (Itgam), transcript variant 1, mRNA [NM_001082960] KLA 1.04 1.12 1.14 1.07 1.54 1.80 1.72
ATP 1.17 1.19 .97 1.16 .86 .65 1.33
KLA/ATP 1.19 1.19 .94 1.06 .64 .59 1.08
Itgam
KLA  ATP  ATP+KLA
 NM_008401 integrin alpha M (Itgam), transcript variant 2, mRNA [NM_008401] KLA 1.20 1.16 1.21 1.34 1.59 1.79 1.64
ATP 1.15 1.16 .94 1.20 1.00 .78 1.25
KLA/ATP 1.32 1.37 1.29 1.14 .84 .75 1.16
Itgb1
KLA  ATP  ATP+KLA
 NM_010578 integrin beta 1 (fibronectin receptor beta) (Itgb1), mRNA [NM_010578] KLA 1.05 1.09 1.13 .92 1.01 .93 .88
ATP 1.14 1.30 .92 1.07 1.04 .83 .70
KLA/ATP 1.26 1.30 .87 1.02 .66 .65 .62
Itgb1
KLA  ATP  ATP+KLA
 U37029 integrin beta1D mRNA, partial cds. [U37029] KLA .93 .95 .96 1.01 .97 1.01 .98
ATP 1.05 .99 .99 1.03 1.03 .97 .94
KLA/ATP .99 .98 1.04 .97 1.02 1.01 .99
Itgb2
KLA  ATP  ATP+KLA
 NM_008404 integrin beta 2 (Itgb2), mRNA [NM_008404] KLA .78 .78 .97 .74 1.04 .94 1.14
ATP 1.24 1.23 .79 .95 1.12 .84 1.10
KLA/ATP .99 1.01 .60 .83 .78 .73 .99
Itgb2l
KLA  ATP  ATP+KLA
 NM_008405 integrin beta 2-like (Itgb2l), mRNA [NM_008405] KLA .87 .98 .98 1.00 1.05 1.07 1.10
ATP 1.24 1.23 1.13 1.14 1.29 1.05 1.05
KLA/ATP 1.02 1.08 1.08 1.06 .98 .93 .95
Jun
KLA  ATP  ATP+KLA
 NM_010591 Jun oncogene (Jun), mRNA [NM_010591] KLA 1.08 .96 1.09 1.09 .75 .88 .81
ATP 1.26 1.48 4.45 8.73 4.02 1.16 1.99
KLA/ATP 1.12 1.38 3.52 5.17 3.32 .49 1.42
Ly96
KLA  ATP  ATP+KLA
 NM_016923 lymphocyte antigen 96 (Ly96), mRNA [NM_016923] KLA 2.25 2.07 2.39 2.38 2.38 2.30 2.14
ATP 1.19 1.02 1.35 1.20 1.69 2.83 1.93
KLA/ATP 2.36 2.28 3.07 2.62 2.68 2.34 3.13
Mapk1
KLA  ATP  ATP+KLA
 NM_001038663 mitogen-activated protein kinase 1 (Mapk1), transcript variant 2, mRNA [NM_001038663] KLA .97 1.03 .93 .86 .79 1.01 1.04
ATP .96 1.18 1.01 1.13 .84 1.04 1.16
KLA/ATP .99 .99 .84 .87 .63 .96 1.26
Mapk1
KLA  ATP  ATP+KLA
 NM_011949 mitogen-activated protein kinase 1 (Mapk1), transcript variant 1, mRNA [NM_011949] KLA .88 .80 .80 .73 .75 .76 .65
ATP .97 .96 1.06 .88 .90 .68 .48
KLA/ATP .82 .81 .78 .65 .64 .64 .45
Mapk10
KLA  ATP  ATP+KLA
 AK076990 adult male testis cDNA, RIKEN full-length enriched library, clone:4930597C01 product:mitogen activated protein kinase 10, full insert sequence. [AK076990] KLA 1.03 1.05 .98 1.04 .94 .95 1.02
ATP 1.00 .99 1.06 .97 1.01 .96 .99
KLA/ATP 1.07 1.01 .95 1.05 .82 .95 .87
Mapk10
KLA  ATP  ATP+KLA
 NM_009158 mitogen-activated protein kinase 10 (Mapk10), transcript variant 1, mRNA [NM_009158] KLA .95 1.00 .97 1.01 .99 1.01 .95
ATP 1.01 1.02 .98 1.01 1.04 1.01 .99
KLA/ATP 1.05 .99 1.01 .98 .92 .97 .98
Mapk11
KLA  ATP  ATP+KLA
 NM_011161 mitogen-activated protein kinase 11 (Mapk11), mRNA [NM_011161] KLA 1.28 1.30 1.41 1.46 1.58 1.29 .98
ATP .96 .95 .89 .82 .79 1.09 .85
KLA/ATP 1.44 1.42 1.32 1.23 1.23 .74 .66
Mapk12
KLA  ATP  ATP+KLA
 NM_013871 mitogen-activated protein kinase 12 (Mapk12), mRNA [NM_013871] KLA .94 .86 .87 .81 .77 .68 .49
ATP .97 .83 .92 .90 .86 .90 .51
KLA/ATP .91 .89 .88 .85 1.12 1.14 .53
Mapk13
KLA  ATP  ATP+KLA
 NM_011950 mitogen-activated protein kinase 13 (Mapk13), mRNA [NM_011950] KLA 1.22 1.21 1.35 1.26 1.24 1.13 1.01
ATP 1.08 1.00 1.20 1.20 1.13 1.22 1.39
KLA/ATP 1.22 1.27 1.30 1.30 1.21 1.11 1.47
Mapk14
KLA  ATP  ATP+KLA
 NM_011951 mitogen-activated protein kinase 14 (Mapk14), mRNA [NM_011951] KLA .70 .70 .62 .54 .67 .88 1.11
ATP 1.03 .98 .87 .69 .48 .78 .66
KLA/ATP .74 .68 .52 .46 .38 .45 .62
Mapk3
KLA  ATP  ATP+KLA
 NM_011952 mitogen-activated protein kinase 3 (Mapk3), mRNA [NM_011952] KLA .81 .85 .88 .72 .79 .73 .90
ATP 1.13 1.30 .92 1.48 1.08 .68 1.03
KLA/ATP 1.01 1.01 .66 1.13 .77 .77 1.16
Mapk8
KLA  ATP  ATP+KLA
 AK162915 adult male spinal cord cDNA, RIKEN full-length enriched library, clone:A330031O19 product:mitogen activated protein kinase 8, full insert sequence [AK162915] KLA .94 .86 .80 .83 .77 .85 .83
ATP 1.08 1.12 .94 .80 .83 .71 .75
KLA/ATP .83 .81 .80 .74 .74 .75 .67
Mapk8
KLA  ATP  ATP+KLA
 AK163829 16 days embryo head cDNA, RIKEN full-length enriched library, clone:C130070A06 product:mitogen activated protein kinase 8, full insert sequence [AK163829] KLA .65 .61 .66 .70 .90 1.02 1.03
ATP .99 .94 1.68 1.44 1.75 1.84 1.10
KLA/ATP .63 .67 1.11 1.00 2.01 1.68 1.15
Mapk8
KLA  ATP  ATP+KLA
 NM_016700 mitogen-activated protein kinase 8 (Mapk8), mRNA [NM_016700] KLA .96 1.00 .94 .96 .94 .99 1.04
ATP 1.01 1.05 1.01 .99 1.03 .98 1.02
KLA/ATP .96 .97 .96 .97 .93 .94 .96
Mapk9
KLA  ATP  ATP+KLA
 NM_016961 mitogen-activated protein kinase 9 (Mapk9), transcript variant 2, mRNA [NM_016961] KLA 1.28 1.37 1.59 1.60 1.61 1.43 1.38
ATP 1.03 .99 .74 .71 .79 1.20 1.01
KLA/ATP 1.53 1.30 1.07 .99 .83 1.10 1.40
Mapk9
KLA  ATP  ATP+KLA
 NM_207692 mitogen-activated protein kinase 9 (Mapk9), transcript variant 1, mRNA [NM_207692] KLA 1.39 1.53 1.69 1.69 1.55 1.44 1.51
ATP .95 .92 .75 .85 .70 1.46 1.17
KLA/ATP 1.37 1.35 .99 1.18 .91 1.22 1.62
Mm.14928
0
KLA  ATP  ATP+KLA
 34328395 Unknown KLA 1.35 1.44 1.59 1.51 1.51 1.28 1.54
ATP .98 .97 1.05 1.08 1.19 .75 .71
KLA/ATP 1.31 1.34 1.22 1.42 1.28 .89 .95
Mm.27682
6
KLA  ATP  ATP+KLA
 126513132 Unknown KLA .74 .69 .83 .96 .93 .97 1.21
ATP .71 .66 .60 .75 .88 .90 .79
KLA/ATP .63 .57 .63 .72 .89 .99 .90
Mm.27970
KLA  ATP  ATP+KLA
 13994135 Unknown KLA 1.06 1.11 1.16 1.07 1.11 1.08 .95
ATP 1.02 1.09 1.05 1.05 .94 1.16 1.32
KLA/ATP 1.10 1.19 1.11 1.04 1.08 1.02 1.33
Mm.33486
1
KLA  ATP  ATP+KLA
 118130835 Unknown KLA 4.31 4.00 3.86 3.23 1.64 .99 1.00
ATP .90 .84 .83 .64 .57 .68 1.29
KLA/ATP 3.81 3.99 4.71 3.39 2.79 1.20 .80
Mm.38049
KLA  ATP  ATP+KLA
 118130391 Unknown KLA .67 .65 .73 .92 .63 .81 .76
ATP .93 .92 1.08 .54 .45 1.48 1.56
KLA/ATP .57 .65 .98 .67 .44 .78 1.16
Mm.46002
4
KLA  ATP  ATP+KLA
 38348245 Unknown KLA 1.22 1.25 1.25 1.19 1.22 1.47 1.14
ATP 1.03 .94 1.01 1.01 2.67 2.31 1.37
KLA/ATP 1.35 1.19 1.27 1.22 1.99 1.83 1.45
Mm.874
KLA  ATP  ATP+KLA
 6754317 Unknown KLA 24.98 24.87 26.43 39.61 12.88 8.64 1.63
ATP 1.97 3.50 11.05 28.47 38.30 10.44 .65
KLA/ATP 23.45 29.37 58.52 51.77 30.64 14.61 8.63
Myd88
KLA  ATP  ATP+KLA
 NM_010851 myeloid differentiation primary response gene 88 (Myd88), mRNA [NM_010851] KLA 3.35 3.51 3.91 4.13 4.13 3.62 2.53
ATP .99 .96 .79 .75 .93 2.15 1.60
KLA/ATP 3.37 3.52 3.52 3.48 2.81 3.03 3.33
Nfkb1
KLA  ATP  ATP+KLA
 BC050841 nuclear factor of kappa light chain gene enhancer in B-cells 1, p105, mRNA (cDNA clone IMAGE:6392793), complete cds. [BC050841] KLA 5.81 4.96 4.77 3.21 3.37 2.00 1.71
ATP 1.39 1.52 3.25 12.63 13.64 4.80 1.08
KLA/ATP 7.21 8.69 19.53 23.93 11.70 2.85 2.01
Nfkb1
KLA  ATP  ATP+KLA
 M57999 gb|Mouse transcription factor NF-kappa-B DNA binding subunit mRNA, complete cds. [M57999] KLA 8.55 7.87 7.35 6.13 3.51 1.85 1.38
ATP .98 .96 1.21 3.06 5.29 4.67 .69
KLA/ATP 7.32 7.20 8.71 10.82 5.55 2.77 1.54
Nlrp3
KLA  ATP  ATP+KLA
 NM_145827 NLR family, pyrin domain containing 3 (Nlrp3), mRNA [NM_145827] KLA 4.67 4.59 4.29 3.00 4.04 2.15 1.70
ATP 1.00 1.06 1.26 4.90 5.57 4.69 .69
KLA/ATP 4.03 4.02 2.51 5.32 2.64 4.12 2.61
Nod1
KLA  ATP  ATP+KLA
 NM_172729 nucleotide-binding oligomerization domain containing 1 (Nod1), mRNA [NM_172729] KLA 25.78 23.94 24.21 25.85 17.65 20.45 9.89
ATP .87 .76 1.03 .75 1.29 5.39 1.51
KLA/ATP 22.46 23.31 35.45 21.24 15.96 16.02 13.86
Nos2
KLA  ATP  ATP+KLA
 NM_010927 nitric oxide synthase 2, inducible, macrophage (Nos2), mRNA [NM_010927] KLA 13.50 16.36 25.65 23.25 24.78 15.99 6.48
ATP 1.03 1.03 1.48 1.66 1.65 5.55 1.70
KLA/ATP 16.01 17.41 19.06 25.50 20.84 29.92 29.80
Pycard
KLA  ATP  ATP+KLA
 NM_023258 PYD and CARD domain containing (Pycard), mRNA [NM_023258] KLA 1.48 1.44 1.62 1.81 1.80 1.69 .94
ATP .89 .88 1.00 .84 .52 .30 .62
KLA/ATP 1.32 1.34 1.65 1.38 1.14 .50 .41
Rela
KLA  ATP  ATP+KLA
 NM_009045 v-rel reticuloendotheliosis viral oncogene homolog A (avian) (Rela), mRNA [NM_009045] KLA 2.05 2.05 2.07 1.75 1.83 1.58 1.33
ATP 1.03 1.08 1.10 1.44 1.61 2.48 1.05
KLA/ATP 2.17 2.27 2.05 2.47 1.93 2.35 2.02
Rhoa
KLA  ATP  ATP+KLA
 NM_016802 ras homolog gene family, member A (Rhoa), mRNA [NM_016802] KLA .93 1.00 1.07 .97 1.08 1.06 1.02
ATP .93 .88 .49 .61 .63 .78 1.05
KLA/ATP .94 .92 .59 .63 .61 .78 1.12
Serping1
KLA  ATP  ATP+KLA
 NM_009776 serine (or cysteine) peptidase inhibitor, clade G, member 1 (Serping1), mRNA [NM_009776] KLA 1.45 1.45 1.79 1.55 1.71 1.50 1.27
ATP .98 1.05 1.09 .99 1.06 1.05 1.03
KLA/ATP 1.59 1.55 1.62 1.60 1.51 1.23 1.39
Sftpa1
KLA  ATP  ATP+KLA
 NM_023134 surfactant associated protein A1 (Sftpa1), mRNA [NM_023134] KLA 1.00 1.05 1.03 1.07 1.00 1.01 .99
ATP 1.01 1.01 1.01 1.03 1.04 1.08 1.00
KLA/ATP 1.06 1.02 1.02 .99 1.04 1.02 1.04
Ticam1
KLA  ATP  ATP+KLA
 NM_174989 toll-like receptor adaptor molecule 1 (Ticam1), mRNA [NM_174989] KLA 1.45 1.63 2.02 2.36 3.12 2.34 2.21
ATP 1.16 1.19 .90 2.58 4.78 2.04 1.80
KLA/ATP 1.79 1.71 1.07 2.89 5.60 3.26 3.50
Ticam2
KLA  ATP  ATP+KLA
 NM_173394 toll-like receptor adaptor molecule 2 (Ticam2), mRNA [NM_173394] KLA 1.28 1.35 1.64 1.79 1.80 1.34 2.01
ATP 1.02 1.02 1.00 1.14 1.16 .70 .88
KLA/ATP 1.49 1.50 1.14 1.41 1.13 .89 1.40
Tirap
KLA  ATP  ATP+KLA
 AK081514 16 days embryo head cDNA, RIKEN full-length enriched library, clone:C130027E04 product:toll-interleukin 1 receptor (TIR) domain-containing adaptor protein, full insert sequence [AK081514] KLA 1.36 1.33 1.35 1.41 1.36 1.45 1.22
ATP .93 .87 .82 .45 .78 1.93 1.32
KLA/ATP 1.35 1.37 1.30 .83 1.17 1.75 2.10
Tirap
KLA  ATP  ATP+KLA
 NM_054096 toll-interleukin 1 receptor (TIR) domain-containing adaptor protein (Tirap), mRNA [NM_054096] KLA 1.88 1.70 1.69 1.74 1.82 1.69 1.31
ATP 1.12 1.10 .75 .56 1.03 2.52 1.67
KLA/ATP 1.60 1.75 1.69 1.25 1.41 2.27 3.21
Tlr4
KLA  ATP  ATP+KLA
 NM_021297 toll-like receptor 4 (Tlr4), mRNA [NM_021297] KLA .69 .61 .75 .94 .64 .81 .73
ATP .95 .90 1.12 .56 .47 1.51 1.53
KLA/ATP .57 .62 1.01 .64 .39 .73 1.13
Tnf
KLA  ATP  ATP+KLA
 NM_013693 tumor necrosis factor (Tnf), mRNA [NM_013693] KLA 13.35 12.76 10.71 9.03 10.64 7.39 8.32
ATP 2.01 2.48 8.27 19.20 9.72 4.09 1.49
KLA/ATP 12.72 15.76 12.73 17.34 5.10 3.61 6.07
Traf6
KLA  ATP  ATP+KLA
 NM_009424 Tnf receptor-associated factor 6 (Traf6), mRNA [NM_009424] KLA 1.19 1.28 1.34 1.20 1.23 1.23 1.28
ATP 1.06 1.12 .92 1.15 2.46 1.84 1.40
KLA/ATP 1.32 1.37 .89 1.16 1.45 1.49 1.46
Zp3r
KLA  ATP  ATP+KLA
 NM_009581 zona pellucida 3 receptor (Zp3r), mRNA [NM_009581] KLA 1.00 1.07 1.02 1.08 1.07 1.11 1.02
ATP .96 1.09 .98 1.14 1.01 1.00 .96
KLA/ATP 1.07 1.00 .94 1.02 .99 .99 1.00